Oral vinorelbine in metastatic breast cancer

被引：0
|
作者：
PF Conte
S Giovannelli
机构：
[1] University Hospital,Division of Medical Oncology, Department of Oncology and Haematology
[2] University of Modena and Reggio Emilia,undefined
来源：
Breast Cancer Research | / 7卷 / Suppl 1期
关键词：
Neutropenia; Docetaxel; Trastuzumab; Metastatic Breast Cancer; Capecitabine;
D O I：
10.1186/bcr1229
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] High safety profile and activity of oral vinorelbine in an elderly patient with metastatic breast cancer
    Rossi, David
    Baldelli, Anna Maria
    Catalano, Vincenzo
    Casadei, Virginia
    Alessandroni, Paolo
    Giordani, Paolo
    Graziano, Francesco
    Fedeli, Stefano Luzi
    BREAST CANCER, 2012, 19 (03) : 275 - 277
  • [22] High safety profile and activity of oral vinorelbine in an elderly patient with metastatic breast cancer
    David Rossi
    Anna Maria Baldelli
    Vincenzo Catalano
    Virginia Casadei
    Paolo Alessandroni
    Paolo Giordani
    Francesco Graziano
    Stefano Luzi Fedeli
    Breast Cancer, 2012, 19 : 275 - 277
  • [23] Oral Vinorelbine in combination with capecitabine: phase I study in patients with metastatic breast cancer
    Nole, F.
    Catania, C.
    Sanna, G.
    Munzone, E.
    Corsetto, L.
    Longerey, B.
    Saindon, A.
    Brandely, M.
    EJC SUPPLEMENTS, 2004, 2 (03): : 134 - 134
  • [24] Oral vinorelbine/paclitaxel combination treatment of metastatic breast cancer: a phase I study
    Delva, R.
    Pienkowski, T.
    Tubiana, N.
    Vanhoefer, U.
    Longerey, B.
    Douville, I.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2007, 59 (06) : 703 - 709
  • [25] Epirubicin-vinorelbine intravenous combination followed by oral vinorelbine as first-line treatment in metastatic breast cancer
    Ardizzoia, Antonio
    Colombo, Ilaria
    Giordano, Monica
    Aglione, Stefania
    Isa, Luciano
    Scanni, Alberto
    Scognamiglio, Giovanni
    Bertolini, Alessandro
    Villa, Federica
    Gardani, Gianstefano
    TUMORI JOURNAL, 2007, 93 (06): : 544 - 549
  • [26] Oral vinorelbine and capecitabine as first-line therapy in metastatic breast cancer: a retrospective analysis
    Valerio, Maria Rosaria
    Spadaro, Pietro
    Arcana, Concetta
    Borsellino, Nicolo
    Cipolla, Calogero
    Vigneri, Paolo
    Piazza, Dario
    Gebbia, Vittorio
    FUTURE SCIENCE OA, 2021, 7 (10):
  • [27] A Phase II Trial of Oral Vinorelbine and Capecitabine in Anthracycline Pretreated Patients with Metastatic Breast Cancer
    Finek, Jindrich
    Holubec, Lubos, Jr.
    Svoboda, Tomas
    Sefrhansova, Lucie
    Pavlikova, Ivana
    Votavova, Marie
    Sediva, Marcela
    Filip, Stanislav
    Kozevnikova, Renata
    Kormunda, Stanislav
    ANTICANCER RESEARCH, 2009, 29 (02) : 667 - 670
  • [28] A phase I trial of oral metronomic vinorelbine plus capecitabine in patients with metastatic breast cancer
    Saridaki, Zacharenia
    Malamos, Nikolaos
    Kourakos, Panagiotis
    Polyzos, Aristides
    Ardavanis, Alexandros
    Androulakis, Nikolaos
    Kalbakis, Kostas
    Vamvakas, Lambros
    Georgoulias, Vassilis
    Mavroudis, Dimitris
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2012, 69 (01) : 35 - 42
  • [29] A phase I trial of oral metronomic vinorelbine plus capecitabine in patients with metastatic breast cancer
    Zacharenia Saridaki
    Nikolaos Malamos
    Panagiotis Kourakos
    Aristides Polyzos
    Alexandros Ardavanis
    Nikolaos Androulakis
    Kostas Kalbakis
    Lambros Vamvakas
    Vassilis Georgoulias
    Dimitris Mavroudis
    Cancer Chemotherapy and Pharmacology, 2012, 69 : 35 - 42
  • [30] Combination of oral capecitabine and vinorelbine in metastatic breast cancer: A retrospective analysis of activity and tolerability profile
    Arcana, C.
    Ingemi, M. C.
    Parra, H. J. Soto
    Iorfida, M.
    Spadaro, P.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
12345